| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.14B | +6.1% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 25.5% | Net margin -11.4% |
| Revenue Q/Q | -5.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 74.5% |
| R&D | ¥0.01B | 4.7% |
| SG&A | ¥0.03B | 18.0% |
| Tax & other | ¥-0.00B | -2.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐 ・ 福赛科技 ・ 春光集团 ・ 威马农机 ・ 浙江华远 ・ 星宸科技 ・ 骏鼎达 ・ 宏鑫科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies